Abstract
Background
Reminiscence therapy is revealed to improve cognitive function and attenuate psychological disorders in neurological diseases such as Alzheimer’s disease patients, while its application in acute ischemic stroke (AIS) is seldom reported. So, the current study aimed to explore the effect of reminiscence therapy on cognitive impairment, anxiety, depression, and disease recurrence in AIS patients.
Methods
A total of 216 first-ever AIS patients were enrolled and randomized into reminiscence therapy group or control group in 1:1 ratio. MMSE, HADS, and Zung SAS/SDS scales were evaluated at the discharge from hospital (M0), 3 months (M3), 6 months (M6), 9 months (M9), and 12 months (M12), respectively. Besides, patients were further followed up to 36 months for recurrence-free survival (RFS) calculation.
Results
Reminiscence therapy group showed higher MMSE score at M9 and M12, lower cognitive impairment rate by MMSE at M12 compared to control group. As to anxiety, HADS-anxiety score and anxiety rate by HADS were of no difference at each time point, while SAS score and anxiety rate by SAS were lower at M12 in reminiscence therapy group compared with control group. Regarding depression, HADS-depression score and depression rate by HADS at M12, SDS score at M9 and M12, and depression rate by SDS at M12 were all lower in reminiscence therapy group compared with control group. In terms of RFS, it was similar between reminiscence therapy group and control group.
Conclusion
Reminiscence therapy cripples cognitive impairment, anxiety, and depression, but does not affect RFS in AIS patients, indicating its potential for post-stroke management.
Similar content being viewed by others
References
Phipps MS, Cronin CA (2020) Management of acute ischemic stroke. BMJ 368:l6983
Chowdhury SZ, Santana Baskar P, Bhaskar S et al (2021) Effect of pre-hospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: a systematic review and meta-analysis. Acad Emerg Med
Muresanu DF, Strilciuc S, Stan A et al (2019) Current drug treatment of acute ischemic stroke: challenges and opportunities. CNS Drugs 33(9):841–847
Rabinstein AA (2020) Update on treatment of acute ischemic stroke. Continuum (Minneap Minn) 26(2):268–286
Zhang S, Xu M, Liu ZJ et al (2020) Neuropsychiatric issues after stroke: clinical significance and therapeutic implications. World J Psychiatry 10(6):125–138
Zhang L, Zhang T, Sun Y et al (2019) A newly designed intensive caregiver education program reduces cognitive impairment, anxiety, and depression in patients with acute ischemic stroke. Braz J Med Biol Res 52(9):e8533
Naess H, Lunde L, Brogger J et al (2012) The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the Bergen Stroke Study. Vasc Health Risk Manag 8:407–413
Baccaro A, Wang YP, Candido M et al (2019) Post-stroke depression and cognitive impairment: study design and preliminary findings in a Brazilian prospective stroke cohort (EMMA study). J Affect Disord 245:72–81
Kowalska K, Krzywoszanski L, Dros J et al (2020) Early depression independently of other neuropsychiatric conditions, influences disability and mortality after stroke (Research Study-Part of PROPOLIS Study). Biomedicines 8 (11):
Dossa A, Glickman ME, Berlowitz D et al (2011) Association between mental health conditions and rehospitalization, mortality, and functional outcomes in patients with stroke following inpatient rehabilitation. BMC Health Serv Res 11:311
Pittiglio L (2000) Use of reminiscence therapy in patients with Alzheimer’s disease. Lippincotts Case Manag 5(6):216–220
Lok N, Bademli K, Selcuk-Tosun A et al (2019) The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: randomized controlled trial. Int J Geriatr Psychiatry 34(1):47–53
Perez-Saez E, Justo-Henriques SI, Alves Apostolo JL et al (2021) Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: analysis of a sample of older adults with Alzheimer's disease and vascular dementia. Clin Neuropsychol 1–22.
Liu M, Li Y (2021) Reminiscence therapy-based care program relieves anxiety, depression, and improves quality of life in post-operational non-small cell lung cancer patients. Clin Respir J
Wu D, Chen T, Huang X et al (2020) The role of old photos in reminiscence therapy in elderly women with depressive symptoms: a functional magnetic resonance imaging study. Biol Res Nurs 22(2):234–246
Duru Asiret G, Dutkun M (2018) The effect of reminiscence therapy on the adaptation of elderly women to old age: a randomized clinical trial. Complement Ther Med 41:124–129
Cumming TB, Churilov L, Linden T, Bernhardt J (2013) Montreal Cognitive Assessment and Mini-Mental State Examination are both valid cognitive tools in stroke. Acta Neurol Scand 128(2):122–129
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Gainotti G, Cianchetti C, Taramelli M, Tiacci C (1972) The guided self-rating anxiety-depression scale for use in clinical psychopharmacology. Act Nerv Super (Praha) 14(1):49–51
Zung WW, Gianturco JA (1971) Personality dimension and the Self-Rating Depression Scale. J Clin Psychol 27(2):247–248
Wang Q, Wills M, Han Z et al (2020) Mini review (Part I): an experimental concept on exercise and ischemic conditioning in stroke rehabilitation. Brain Circ 6(4):242–247
Sun XG, Zhang N, Wang T et al (2013) Public and professional education on urgent therapy for acute ischemic stroke: a community-based intervention in Changsha. Neurol Sci 34(12):2131–2135
Zhang X, Liu Y, Cao X et al (2020) Effect of multi-level stroke education on treatment and prognosis of acute ischemic stroke. Exp Ther Med 20(3):2888–2894
Li M, Lyu JH, Zhang Y et al (2020) Efficacy of group reminiscence therapy on cognition, depression, neuropsychiatric symptoms, and activities of daily living for patients with Alzheimer disease. J Geriatr Psychiatry Neurol 33(5):272–281
Imtiaz D, Khan A, Seelye A et al (2018) A mobile multimedia reminiscence therapy application to reduce behavioral and psychological symptoms in persons with Alzheimer’s. J Healthc Eng 2018:1536316
Redulla R (2020) Reminiscence therapy for dementia. Issues Ment Health Nurs 41(3):265–266
Cuevas PEG, Davidson PM, Mejilla JL, Rodney TW (2020) Reminiscence therapy for older adults with Alzheimer’s disease: a literature review. Int J Ment Health Nurs 29(3):364–371
Sanner Beauchamp JE, Casameni Montiel T, Cai C et al (2020) A retrospective study to identify novel factors associated with post-stroke anxiety. J Stroke Cerebrovasc Dis 29(2):104582
Carnes-Vendrell A, Deus J, Molina-Seguin J et al (2019) Depression and apathy after transient ischemic attack or minor stroke: prevalence. Evolution and Predictors Sci Rep 9(1):16248
Lopez-Espuela F, Roncero-Martin R, Canal-Macias ML et al (2020) Depressed mood after stroke: predictive factors at six months follow-up. Int J Environ Res Public Health 17 (24):
Tsehayneh F, Tafesse A (2020) High prevalence of poststroke depression in ischemic stroke patients in Ethiopia. Neurol Res Int 2020:8834299
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consents
All patients signed the informed consents. This study was approved by the Institutional Review Board.
Competing interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Li, A., Liu, Y. Reminiscence therapy serves as an optional nursing care strategy in attenuating cognitive impairment, anxiety, and depression in acute ischemic stroke patients. Ir J Med Sci 191, 877–884 (2022). https://doi.org/10.1007/s11845-021-02600-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-021-02600-8